Delivery Order SPE2DB24D2205-SPE2DB25FEBMQ
- Not listed
- This federal contract award, valued at $1,753.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and is for the supply of Colestipol HCL 1 GM Tablets in quantities of 120 tablets. The award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division for the provision of 4,564,840,868 units of Colestipol Hydrochloride 1 gram tablets. The delivery order has a ceiling value of $5,068.32 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs...
- This federal contract award is a delivery order with a firm fixed price ceiling value of $1,054.44, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of Colestipol HCl 1 GM Tablets in 120-count packages, with a period of performance through June 12, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,348.33 firm fixed price contract is for the delivery of 4,564,286,736 colestipol hydrochloride 1 gram tablets. This award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, to provide a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol HCL 1 GM Tablets, with a ceiling value of $1,157.80 and a performance period ending on May 20, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,750 delivery order to Amerisourcebergen Drug Corporation for 120 bottles of Colestipol HCL 1 gram tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning June 23 through June 26, 2023. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested generic cholesterol medication to support the DLA's logistics operations. No...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $240 firm fixed price delivery order contract to supply 120 tablets of 1 gram Colestipol HCL to the Defense Logistics Agency Troop Support Medical. To be performed in Conshohocken, Pennsylvania by October 13, 2023, this contract was awarded without a set-aside designation to fulfill the agency's requirements for the pharmaceutical product. As the prime contractor, Amerisourcebergen Drug Corp will...
- The Defense Logistics Agency awarded a $1,169.68 delivery order contract to Amerisourcebergen Drug Corp for 120 tablets of colestipol hydrochloride 1 gram. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to a facility in Conshohocken, Pennsylvania by June 29, 2023 under a firm fixed price contract. The parent company, Amerisourcebergen Corporation, will perform through its Amerisourcebergen Corporation Division. No subcontractors or set...
- The Defense Logistics Agency awarded a $1,306 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 tablets of colestipol hydrochloride 1 gram. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a customer located in Conshohocken, Pennsylvania by July 18, 2023 under the terms of this order. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $8,874.47 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 120 tablets of colestipol hydrochloride 1 gram each. Performance will take place in Conshohocken, Pennsylvania over a three day period concluding on July 3, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the United States armed forces through...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEBMQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,854.08 to AmerisourceBergen Drug Corp for Colestipol HCl 1 GM tablets (120-count supply) with an ultimate completion date of April 28, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies—including specialty medications, generic and brand-name drugs, vaccines, and medical devices—to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The Colestipol HCl tablets supplied under this order support cardiovascular and cholesterol management therapeutic needs within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 4/25/25 |